22nd century group completes sale of hemp/cannabis franchise

Sale will significantly reduce operating expenses, ultimately reduce debt by $5.2 million buffalo, new york--(newsfile corp. - december 28, 2023) - 22nd century group, inc. (nasdaq: xxii) (the "company" or "22nd century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has closed the sale of its hemp/cannabis operations. the transaction will significantly reduce the company's operating costs going forward, a key step in its goal to achieve cash positive operations.
XXII Ratings Summary
XXII Quant Ranking